Wild-type cutoff for Apramycin against Escherichia coli

BACKGROUND: Apramycin is used exclusively for the treatment of Escherichia coli (E.coli) infections in swine around the world since the early 1980s. Recently, many research papers have demonstrated that apramycin has significant in vitro activity against multidrug-resistant E.coli isolated in hospit...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yuqi, Xiao, Tianshi, Li, Jiarui, Cheng, Ping, Li, Fulei, Yu, Hongxiao, Liu, Ruimeng, Muhammad, Ishfaq, Zhang, Xiuying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448428/
https://www.ncbi.nlm.nih.gov/pubmed/32847547
http://dx.doi.org/10.1186/s12917-020-02522-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448428/
https://www.ncbi.nlm.nih.gov/pubmed/32847547
http://dx.doi.org/10.1186/s12917-020-02522-0

Ejemplares similares